Rajesh Kumar Kainthan
24Patents
7h-index
34Co-inventors
65Inventor score
Filing activity: Jun 6, 2006 → Mar 1, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9492559B2 | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | Emerging Cross-Sectional Technologies | 36 | Active |
| US10226525B2 | Group B Streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof | Emerging Cross-Sectional Technologies | 13 | Active |
| US9687550B2 | Compositions for nucleic acid delivery | Chemistry; Metallurgy | 12 | Active |
| US10668164B2 | Immunogenic glycoprotein conjugates | Chemistry; Metallurgy | 11 | Active |
| US10392420B2 | Glycoconjugation process | Emerging Cross-Sectional Technologies | 10 | Active |
| US10745438B2 | Glycoconjugation process | Emerging Cross-Sectional Technologies | 9 | Active |
| US10105431B2 | Streptococcus pneumoniae capsular polysaccharides and conjugates thereof | Human Necessities | 9 | Active |
| US11090375B2 | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | Emerging Cross-Sectional Technologies | 5 | Active |
| US11160855B2 | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | Emerging Cross-Sectional Technologies | 5 | Active |
| US10918708B2 | Streptococcus pneumoniae capsular polysaccharides and conjugates thereof | Human Necessities | 4 | Active |
| US11117928B2 | Glycoconjugation process | Emerging Cross-Sectional Technologies | 4 | Active |
| US10946086B2 | Group B Streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof | Emerging Cross-Sectional Technologies | 3 | Active |
| US9186410B2 | Derivatized hyperbranched polyglycerols | Chemistry; Metallurgy | 3 | Active |
| US9346029B2 | Polymer-based serum albumin substitute | Chemistry; Metallurgy | 2 | Active |
| US9561278B2 | Derivatized hyperbranched polyglycerols | Chemistry; Metallurgy | 1 | Active |
| US11426456B2 | Streptococcus pneumoniae capsular polysaccharides and conjugates thereof | Human Necessities | 1 | Active |
| US9789056B2 | Polymer-based serum albumin substitute | Chemistry; Metallurgy | 0 | Active |
| US10525131B2 | Derivatized hyperbranched polyglycerols | Chemistry; Metallurgy | 0 | Active |
| US10071160B2 | Derivatized hyperbranched polyglycerols | Chemistry; Metallurgy | 0 | Active |
| US11707529B2 | Immunogenic glycoprotein conjugates | Chemistry; Metallurgy | 0 | Active |
| US12343389B2 | Streptococcus pneumoniae capsular polysaccharides and conjugates thereof | Human Necessities | 0 | Active |
| US11872274B2 | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12234259B2 | Glycoconjugation process | Emerging Cross-Sectional Technologies | 0 | Active |
| US11603384B2 | Glycoconjugation process | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.